Teplizumab

From Self-sufficiency
Revision as of 13:55, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Teplizumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD3
Identifiers
CAS Number 876387-05-2
ATC code none
Chemical data
Formula C6462H9938N1738O2022S46
Molar mass 145.8 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Teplizumab is a monoclonal antibody which is used as an immunosuppressive drug. It is in Phase-3 clinical trials for Type-1 DM. It targets at protecting the remaining beta cells in newly diagnosed T-1 diabetics. It has been used experimentally in type 1 diabetes mellitus[1], but "these agents [i. e. anti-CD3-antibodies] alone do not restore normal glucose control".[2]

Teplizumab is a humanized Fc-engineered monoclonal antibody also known as MGA031 and hOKT3γ1(Ala-Ala).[3][4]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links


  1. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  3. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  4. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.